The only technical publication devoted exclusively to readers involved in development and production of orally inhaled and nasal drug products (OINDPs).


In vitro methods for estimation of total and regional lung deposition of orally inhaled products

An overview of The European Pharmaceutical Aerosol Group (EPAG)

Back Pages:

A molecule responsible for airway remodeling
Airway response and development of asthma in some allergic patients

Cross-Industry Organizations:

Drug Delivery to the Lungs: Highlights of DDL2022 and a look at DDL2023

The effects of inhaler type and orientation at inhalation on dosing efficiency—a study of the SMI, pMDI and DPI

Unintended consequences of new US law to protect allergic consumers from sesame allergen

Back Pages:

Air quality monitoring where asthma is most prevalent

US EPA supports air quality monitoring in 37 states

From the Archive:

Nasal drug delivery devices: Past, present and future device innovations for the would-be product developer


Industry Organizations

Inhalation 1-2-3

Reference & Buyer’s Resource

Editorial Advisory Board




White Papers